TAM
MRNS

Tocqueville Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Tocqueville Asset Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,750
Closed -$24K – 740
2019
Q4 		$24K Sell
2,750
-625
-19% -$3.51K ﹤0.01% 722
2019
Q3 		$21K Buy
+3,375
New +$27.3K ﹤0.01% 743

Other funds holding MRNS

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Tocqueville Asset Management's MRNS Position: Q1 2020 in Review

Tocqueville Asset Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2020, closing a stake of 2,750 shares — an estimated $24K sold.

Tocqueville Asset Management first reported a position in MRNS in Q3 2019 and held it in 2 quarters. The position peaked at $24K in Q4 2019. 74 funds tracked by Wall St. Rank hold MRNS as of Q1 2020.

  • Tocqueville Asset Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2020 after selling out during the quarter.
  • Tocqueville Asset Management sold 2,750 Marinus Pharmaceuticals, Inc shares in Q1 2020, an estimated $24K.
  • Tocqueville Asset Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2019 and held it in 2 quarters.
  • Tocqueville Asset Management's Marinus Pharmaceuticals, Inc position peaked at $24K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2020.

Based on Tocqueville Asset Management's 13F filing for Q1 2020, filed 15 May 2020.